日韩精品欧美专区,国产v综合v亚洲欧美久久,jizz性欧美2,国产精品色婷婷

Ask the Experts: Documenting Vaccination

Results (26)

CDC’s “General Best Practices for Immunization” still states that a patient’s self-report of a history of vaccination without any documentation can generally be accepted as proof of vaccination only for influenza and pneumococcal polysaccharide vaccines. The ACIP recommendation for administering a primary series of inactivated polio vaccine to an adult also indicates that adults may generally be presumed to have had a primary series of polio vaccine unless there is a specific reason to believe that they have not been vaccinated against polio. See the Adult Vaccination section at www.cdc.gov/vaccines/hcp/imz-best-practices/vaccination-programs.html#cdc_report_pub_study_section_5-adult-vaccination.

Last reviewed: February 16, 2025

The Food and Drug Administration (FDA) website has a list of all vaccines licensed for use in the United States at www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM093833. Note that some licensed vaccines may not currently be distributed in the United States (for example, the Cervarix brand of HPV vaccine and the Zostavax brand of shingles vaccine).

Last reviewed: February 16, 2025

One way to handle this is to indicate if the vaccination was given either in the “upper” or “lower” portion of the injection area selected (e.g., DTaP: right thigh, upper; Hib: right thigh, lower; or PCV13: left thigh, upper; HepB: left thigh, lower). It is helpful if everyone in your office or clinic uses the same sites for each vaccine. Use of a standardized site map can facilitate this. Here are some helpful site maps for different ages so you can record where shots were given:

For infants and toddlers: www.eziz.org/PDF/IMM-718.pdf

For adults: eziz.org/assets/docs/ADA/IMM-718A.pdf

Last reviewed: February 16, 2025

Vaccination providers frequently encounter people who do not have adequate documentation of vaccinations. Providers should only accept written, dated records as evidence of vaccination. CDC recommends that, with the exception of influenza and pneumococcal polysaccharide vaccines, self-reported doses of vaccine without written documentation should generally not be accepted. The ACIP recommendation for administering a primary series of inactivated polio vaccine to an adult also indicates that adults may generally be presumed to have had a primary series of polio vaccine unless there is a specific reason to believe that they have not been vaccinated against polio. Professional judgment is also required when assessing adults without a record of hepatitis B vaccination: vaccination rates for hepatitis B in childhood have been high since the late 1990s and routine infant HepB vaccination began in 1991. In the absence of a record or of screening results demonstrating evidence of hepatitis B immunity or resolved or chronic infection, if there is any suspicion that the adult was unvaccinated, then vaccination is recommended.

An attempt to locate missing records should be made whenever possible by contacting previous healthcare providers, reviewing state or local immunization information systems (IIS, registries), and searching for a personally held record. However, if records cannot be located or are unavailable anywhere because of the patient’s circumstances, people without adequate documentation should be considered susceptible and should be started on the age-appropriate vaccination schedule. Serologic testing for immunity is an alternative to vaccination for certain antigens (e.g., measles, rubella, or hepatitis A).

In general, although it is not ideal, receiving extra doses of vaccine poses no medical problem. Receiving excessive doses of tetanus toxoid (DTaP, DT, Tdap, or Td) can increase the risk of a local adverse reaction, however. For details, consult the CDC’s? “Best Practices for Immunization” chapter titled Timing and Spacing of Immunobiologics, available at?www.cdc.gov/vaccines/hcp/imz-best-practices/timing-spacing-immunobiologics.html.

Last reviewed: February 16, 2025

If a provider suspects an invalid vaccination, including those from persons vaccinated outside the U.S., one of two approaches can be taken. Repeating the vaccinations is an acceptable option. Doing so is generally safe and avoids the need to obtain and interpret serologic tests. If avoiding unnecessary injections is desired, judicious use of serologic testing might be helpful in determining which immunizations are needed. This may be particularly helpful in determining tetanus and diphtheria antitoxin levels for children whose records indicate 3 or more doses of DTP or DTaP. This issue is discussed in detail in the CDC’s “General Best Practices for Immunization” chapter titled Special Situations, and summarized in Table 9-1, available at?www.cdc.gov/vaccines/hcp/imz-best-practices/special-situations.html.

Last reviewed: February 16, 2025

Healthcare providers (or other covered entities) may share immunization information with schools or daycare facilities, without authorization, if permitted or required by state law. These state laws would not be preempted by the HIPAA Privacy Rule [45 CFR 160.203(c)].

Last reviewed: February 16, 2025

There is no federal law requiring a refusal form. Several major medical organizations, including the American Academy of Pediatrics, have stated that healthcare providers may decide it is in their best interest to formally document a parent’s refusal to accept vaccination for their (minor) child. To read a discussion on this topic and to access a prototype refusal form, see “Record of Vaccine Declination” that can be accessed at www.immunize.org/catg.d/p4059.pdf.

Last reviewed: February 16, 2025

As of 2021, every state has an IIS that is capable of accepting and storing immunization records on individuals of all ages. To find out the status of the IIS in your state you should contact your state IIS program or your state immunization program. CDC maintains a listing of contact information for all state IIS programs at?www.cdc.gov/iis/contacts-locate-records/.

Last reviewed: February 16, 2025

Patient-held cards are an important part of a person’s medical history. The person may move to another state or need medical care at a facility within or outside the state without access to the IIS in which their records are documented, and the personal record may be the only vaccination record available.

Last reviewed: February 16, 2025

The National Childhood Vaccine Injury Act (NCVIA), enacted in 1986, set forth 3 basic requirements for all vaccination providers, which are:

  • Providers must give the patient (or parent/legal representative of a minor) a copy of the relevant federal “Vaccine Information Statement” (VIS) for the vaccine they are about to receive.
  • Providers must record certain information about the vaccine(s) administered in the patient’s medical record or a permanent office log.
  • Providers must document any adverse event following the vaccination that the patient experiences and that becomes known to the provider, whether or not it is felt to be caused by the vaccine, and submit the report to the Vaccine Adverse Event Reporting System (VAERS) at https://vaers.hhs.gov.
Last reviewed: February 16, 2025

It is important to know the federal requirements for documenting the vaccines administered to your patients. The requirements are defined in the National Childhood Vaccine Injury Act (NCVIA) enacted in 1986. The law applies to all routinely recommended childhood vaccines, and vaccines recommended during pregnancy (except COVID-19 and RSV), regardless of the age of the patient receiving the vaccines.

The RSV preventive antibody, nirsevimab (Beyfortus, Sanofi) is not a vaccine and not covered by the NCVIA, but a VIS-equivalent, known as an immunization information sheet (IIS), should be provided to the caregiver of an infant receiving nirsevimab.

The following information must be documented on the patient’s paper or electronic medical record or on a permanent office log when a vaccine covered by the NCVIA is given, and is recommended when any vaccine is administered:

  1. The vaccine manufacturer
  2. The lot number of the vaccine
  3. The date the vaccine is administered
  4. The name, office address, and title of the healthcare provider administering the vaccine
  5. The Vaccine Information Statement (VIS) edition date located in the lower right corner on the back of the VIS; when administering combination vaccines, all applicable VISs should be given and the individual VIS edition dates recorded
  6. The date the VIS is given to the patient, parent, or guardian

The federally required information should be both permanent and accessible.

Federal law does not require a parent, patient, or guardian to sign a consent form in order to receive a vaccination; providing them with the appropriate VIS(s), IIS, or Emergency Use Authorization (EUA) Fact Sheet (where applicable) and answering their questions is sufficient under federal law.

Last reviewed: February 16, 2025

NCVIA requirements apply to diphtheria, tetanus, pertussis, measles, mumps, rubella, polio, hepatitis A, hepatitis B, Haemophilus influenzae type b (Hib), varicella, seasonal influenza (inactivated and live attenuated), pneumococcal conjugate, meningococcal, rotavirus, and human papillomavirus (HPV) vaccine.

Last reviewed: February 16, 2025

In response to public health emergencies and security dangers, the government supports the development of countermeasures. A countermeasure is a vaccine, medication, device, or other item used to prevent, diagnose, or treat a public health emergency or a security threat.

The Countermeasures Injury Compensation Program (CICP, www.hrsa.gov/cicp) provides compensation for covered serious injuries or deaths that occur as the result of the administration or use of certain countermeasures. Compensation may include unreimbursed medical expenses (expenses that health insurance did not cover), lost employment income, and the survivor death benefit. The Secretary of the Department of Health and Human Services has issued federal declarations under the Public Readiness and Emergency Preparedness Act (PREP Act) that list the countermeasures covered by the CICP. For a list of covered countermeasures and for information about filing a claim, visit www.hrsa.gov/cicp/covered-countermeasures.

Last reviewed: February 16, 2025

The National Childhood Vaccine Injury Act requires that a VIS must be given to parents, legal representatives, or adult patients before administering the vaccine. A VIS must be provided prior to each dose, not just the first dose. Providers should be sure they are using the most current version of each VIS. Current VISs and their dates are available from on the CDC’s website at?www.cdc.gov/vaccines/hcp/vis/index.html?and from Immunize.org’s website at?www.immunize.org/vaccines/vis/about-vis/. Immunize.org offers translations of VISs in dozens of languages. If a translation of a current VIS is unavailable, a usable translation of an earlier English language version is posted when available. Translations should be provided in addition to, not in place of, the current federal VIS (in English).

Last reviewed: February 16, 2025

Instructions on the use of VISs and many additional items are available on the CDC website at?www.cdc.gov/vaccines/hcp/vis/index.html?or from your state immunization program. You can also visit Immunize.org’s website at?www.immunize.org/vaccines/vis/about-vis/ for links to important documents about the use of VISs.

Last reviewed: February 16, 2025

An interim VIS can sometimes be released soon after licensure of the vaccine or after the official vote by ACIP is taken. The interim VIS is not replaced with a final version until the ACIP recommendations have been published and the new VIS has been developed according to legally mandated procedures.

Last reviewed: February 16, 2025

Yes. The National Childhood Vaccine Injury Act requires that a VIS be given to people of any age before they receive a dose of any vaccine included in the Act. Tetanus and diphtheria toxoids (and pertussis vaccine) are included in the Act. If the patient is unaccompanied and unable to clearly read and understand the information in the VIS (e.g., the patient is unconscious), this should be noted in the patient’s chart.

Last reviewed: February 16, 2025

Your solution will meet the spirit of the federal law, as long as you make sure to encourage the patient (or parent) to take home a paper copy of the VIS and to refer to it if needed (e.g., if they need to know what to do if there is an adverse event or how to contact VAERS).

Immunize.org offers another option with its document containing QR codes for all VISs, available at www.immunize.org/wp-content/uploads/catg.d/p2093.pdf. A patient may scan the QR code with their phone to download the current VIS. Provision of an electronic copy of the VIS in this manner complies with federal law.

Last reviewed: February 16, 2025

VISs are required to be given and documented when any vaccine covered by the National Childhood Vaccine Injury Act (NCVIA) is given to a person of any age in any setting, including influenza vaccine. CDC recommends that VISs should be given and documented any time any vaccine is administered, regardless of the recipient’s age and setting.

Current VISs are available from the CDC’s website at?www.cdc.gov/vaccines/hcp/vis/index.html?and from the Immunize.org website at www.immunize.org/translations/, where you will also find many VIS translations in other languages.

Immunize.org offers another option with its document containing QR codes for all VISs available at www.immunize.org/wp-content/uploads/catg.d/p2093.pdf. It also offers a document with QR code links to all available translations of the widely used injectable influenza vaccine VIS (www.immunize.org/wp-content/uploads/catg.d/p2092.pdf) which is especially helpful in busy influenza vaccination clinics. A vaccine recipient or parent of a minor child may scan the QR code with their phone to download the current VIS. Provision of an electronic copy of the VIS in this manner complies with federal law.

Last reviewed: February 16, 2025

If a patient clicks a link or scans a QR code to access an electronic copy of the VIS before vaccination, that complies with federal law to provide the VIS. Immunize.org provides clinical resources displaying QR codes linking to VISs that may be printed out and used in clinics on its “VIS-related resources” page: www.immunize.org/clinical/topic/vis/.

Last reviewed: February 16, 2025

No. There is no federal requirement for signed consent for any dose of a vaccine licensed for use by the FDA. The federal requirement is to provide all adult patients or parents/legal representatives of minor children with the appropriate VIS (or Emergency Use Authorization Fact Sheet, when applicable) for each dose of vaccine administered. Some clinics, agencies, and/or state immunization programs may have requirements for signatures. Contact information for your state health department is available at? www.immunize.org/official-guidance/state-policies/state-resources/.

Last reviewed: February 16, 2025

CDC currently has no plans to develop VISs for combination vaccines such as Pediarix, Twinrix, Kinrix, Quadracel, Pentacel, or Penbraya. When administering these combination vaccines, use the VISs for all component vaccines. For certain combination vaccines given to children, you can use the multi-vaccine VIS (which includes DTaP, Hib, HepB, polio, and PCV) and check the appropriate box(es), just as you would if you were administering the individual vaccines. If the multi-vaccine VIS is unavailable, you should use the individual vaccine VISs. A VIS was developed for MMRV (ProQuad, by Merck) because of its unique adverse reaction profile.

Last reviewed: February 16, 2025

Not necessarily. Providers do not need to discard their existing printed VIS stocks when nothing but the VIS format has been changed. CDC posts information on its website to alert healthcare providers when the older version of a VIS should not be used. This information is available on CDC’s web section titled “What’s New with VISs”, available at www.cdc.gov/vaccines/hcp/vis/what-is-new.html.

Last reviewed: February 16, 2025

CDC began adding barcodes to VISs in 2012. The barcode is intended to save time and prevent documentation errors by allowing immunization providers to scan the name and edition date of the VIS, information required to be documented in the permanent record of immunization, into an electronic medical record, immunization information system, or other electronic database. Scanning the barcode instead of manually recording the information is optional but can be helpful.

Using 2D barcodes requires a 2D barcode scanner and software that is programmed to accept and process data contained in the VIS barcodes. Providers may continue to use any VISs without barcodes as long as the VIS content is otherwise the same. For more information about using barcodes, visit www.cdc.gov/vaccines/hcp/about-vis/barcodes-faq.html.

Last reviewed: February 16, 2025

CDC publishes VISs in English only; all translations have been developed by others. To access all currently available VISs in dozens of languages, go to Immunize.org’s website at? www.immunize.org/translations/.

Last reviewed: February 16, 2025

An Emergency Use Authorization (EUA) fact sheet for vaccine recipients and caregivers is provided to a vaccine recipient (or caregiver) when FDA allows the use of an unapproved vaccine during a public health emergency. For information about EUAs for vaccines, see www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained. The manufacturer prepares an EUA fact sheet for healthcare providers (in place of the package insert found in licensed and approved vaccines), and an EUA fact sheet for recipients and caregivers that informs the recipient, to the extent possible, of the potential benefits and risks of the vaccine, that the recipient has the option to refuse or accept the vaccine, and any available alternatives to the vaccine. An EUA fact sheet should be provided to the recipient before administration and documented in the shot record, as is done with a VIS, when a vaccine is administered under EUA conditions.

Last reviewed: February 16, 2025

This page was updated on .

日韩精品欧美专区,国产v综合v亚洲欧美久久,jizz性欧美2,国产精品色婷婷
99精品视频在线播放观看| 亚洲日本电影在线| 精品久久一区二区| 91免费观看视频在线| 久久99在线观看| 26uuu亚洲婷婷狠狠天堂| 国产性色一区二区| 依依成人精品视频| 亚洲一区二区三区四区中文字幕| 亚洲视频在线一区二区| 国产亚洲精品超碰| 欧美videos大乳护士334| 精品综合免费视频观看| 欧美一区二区三区小说| 91麻豆精品国产无毒不卡在线观看| 欧美一卡二卡在线| 国产清纯在线一区二区www| 欧美午夜一区二区| 欧美欧美欧美欧美首页| 欧美色大人视频| 国内精品伊人久久久久影院对白| 五月婷婷激情综合| 日韩精品视频网| 日韩有码一区二区三区| 国产自产v一区二区三区c| 丝袜诱惑制服诱惑色一区在线观看| 6080国产精品一区二区| 久久精品国产99| 日韩欧美国产三级电影视频| 国产不卡在线视频| 国产麻豆精品95视频| 国产亚洲一区二区在线观看| 久久久久久毛片| 亚洲精品在线观| 亚洲午夜私人影院| 亚洲国产日韩a在线播放| 日韩一区二区免费高清| 欧美综合色免费| 成人精品视频一区二区三区| 日日夜夜精品免费视频| 国内精品视频一区二区三区八戒| 一区二区国产盗摄色噜噜| 欧美一a一片一级一片| 日韩精品中文字幕一区二区三区| 极品尤物av久久免费看| 国内精品久久久久影院薰衣草| 欧美一个色资源| 国产一区二区不卡在线| 天堂久久久久va久久久久| 水蜜桃久久夜色精品一区的特点| 91丨九色丨国产丨porny| 日韩成人免费电影| 亚洲午夜私人影院| 欧美不卡123| 久久久国产午夜精品| 国产一区二区三区电影在线观看| 9久草视频在线视频精品| 亚洲一卡二卡三卡四卡五卡| 国产成人啪午夜精品网站男同| 精品久久久久一区| 一区二区三区精密机械公司| 亚洲综合一二三区| 日韩欧美国产麻豆| 欧美国产1区2区| 亚洲高清不卡在线观看| 在线观看日韩电影| 中文字幕在线不卡一区二区三区| 顶级嫩模精品视频在线看| 又紧又大又爽精品一区二区| 丁香激情综合国产| 99久久精品国产网站| 欧美最新大片在线看| 欧美特级限制片免费在线观看| 欧美精品一区在线观看| 欧美一区二区私人影院日本| 亚洲嫩草精品久久| 国产精品国产a| 国产经典欧美精品| 国产精品一区二区果冻传媒| 欧美人妇做爰xxxⅹ性高电影| 精品女同一区二区| 午夜精品久久久久久| 国产电影一区在线| 国产精品伦一区| 日韩av一区二区三区| 欧美一区二区美女| 日韩精品一区二区三区视频在线观看| 91看片淫黄大片一级在线观看| 欧美一区二区三区精品| 韩国在线一区二区| 蜜臀久久久久久久| 欧美一级一区二区| 午夜精品视频在线观看| 日韩一区二区三区高清免费看看| 国产不卡视频在线播放| 久久亚洲精精品中文字幕早川悠里| 国产午夜精品在线观看| 亚洲精选视频免费看| 亚洲一区在线播放| 国产乱码一区二区三区| 欧美亚洲国产怡红院影院| 亚洲电影激情视频网站| 强制捆绑调教一区二区| 蜜臀av一区二区在线观看| 奇米影视一区二区三区小说| 中文字幕+乱码+中文字幕一区| 国产原创一区二区三区| 99精品在线观看视频| 久久久电影一区二区三区| 成人的网站免费观看| 免费日本视频一区| 欧美一区二区三区视频免费播放| 欧美激情一区不卡| 在线一区二区三区做爰视频网站| 亚洲国产一区二区在线播放| 一本久道久久综合中文字幕| 精品国产髙清在线看国产毛片| 亚洲日本在线看| 26uuu另类欧美亚洲曰本| 亚洲一区二区三区四区在线免费观看| 91在线视频播放| 日韩高清在线一区| 亚洲欧美日韩国产综合在线| 国产亚洲自拍一区| 精油按摩中文字幕久久| 精品国产三级电影在线观看| 成人开心网精品视频| 欧美日韩国产天堂| 国产精品日韩精品欧美在线| 国产精品久久久久婷婷| 亚洲欧美另类久久久精品2019| 91丨porny丨蝌蚪视频| 这里只有精品视频在线观看| 成人深夜福利app| 国产精品1024| 欧美日韩一区在线观看| 免费在线欧美视频| 国产欧美日韩精品在线| 色www精品视频在线观看| 青青草原综合久久大伊人精品| 91福利资源站| 奇米一区二区三区av| 91麻豆蜜桃一区二区三区| 国产三级精品在线| 欧美国产日韩亚洲一区| 国产成a人亚洲| 欧美丰满美乳xxx高潮www| 成人欧美一区二区三区白人| 欧美96一区二区免费视频| 亚洲欧美在线另类| 精品在线你懂的| 欧美mv日韩mv亚洲| 欧美狂野另类xxxxoooo| 欧美性猛交xxxx乱大交退制版| 亚洲少妇中出一区| 欧美男男青年gay1069videost| av电影天堂一区二区在线观看| 成人午夜av在线| 欧美人xxxx| 国产精品麻豆久久久| 免费在线观看视频一区| 久久精品网站免费观看| 视频一区视频二区中文| 国产精品18久久久久久久久| 偷窥少妇高潮呻吟av久久免费| 亚洲蜜桃精久久久久久久| 久久精品一区蜜桃臀影院| 亚洲成av人片在线观看无码| 精品亚洲国产成人av制服丝袜| 日韩欧美久久久| 久久精品亚洲精品国产欧美| 国产不卡视频一区二区三区| 亚洲日本va在线观看| 国产a级毛片一区| 国产精品久线观看视频| 精品久久久影院| 欧美激情一区不卡| 韩国女主播成人在线观看| 成人国产精品视频| 日韩av一区二区在线影视| 在线视频一区二区三| 国产精品一区二区在线观看不卡| 日韩高清一区二区| 欧美一级免费大片| 欧美韩国日本不卡| 久久久综合激的五月天| 欧美国产精品中文字幕| 亚洲精品中文在线影院| 欧美一区二区三区在线电影| 欧美mv和日韩mv的网站| 日本黄色一区二区| 国产精品美女久久久久久久久| 中文无字幕一区二区三区| 97久久久精品综合88久久| 91亚洲午夜精品久久久久久| 日韩视频国产视频| 波多野结衣中文一区| 欧美美女激情18p| 亚洲精品在线免费观看视频| 国产二区国产一区在线观看|